1. Clinical Overview
Xylometazoline is a direct-acting sympathomimetic amine, primarily an alpha-2 adrenergic receptor agonist, used as a topical nasal decongestant. It is a potent vasoconstrictor that acts on the alpha-adrenergic receptors in the arterioles of the nasal mucosa, leading to reduced blood flow, decreased edema, and relief of nasal congestion. It is a standard first-line therapy for symptomatic relief in allergic rhinitis, common cold, and sinusitis in the Indian clinical setting.
| Onset | Duration | Bioavailability |
|---|---|---|
| 5-10 minutes | 8-12 hours (long-acting) | Negligible systemic absorption when used topically as directed (<1%) |
2. Mechanism of Action
Xylometazoline is a potent, selective agonist of postsynaptic alpha-2 adrenergic receptors located on vascular smooth muscle cells within the nasal mucosa. Its activation leads to the constriction of capacitance vessels (venous sinusoids) and arterioles. This vasoconstriction reduces blood flow, decreases capillary permeability, and limits the production of nasal secretions, thereby shrinking the swollen nasal turbinates and relieving obstruction.
3. Indications & Uses
- Symptomatic relief of nasal congestion associated with Allergic Rhinitis (Seasonal & Perennial)
- Symptomatic relief of nasal congestion in Common Cold (Acute Viral Rhinitis)
- Symptomatic relief of nasal congestion in Acute & Chronic Sinusitis
- Symptomatic relief of nasal congestion in Acute Rhinosinusitis
4. Dosage & Administration
Adult Dosage: 0.1% solution/spray: 2-3 drops or 1-2 sprays into each nostril every 8 to 12 hours. Do not exceed 3 applications in 24 hours.
Administration: 1. Blow nose gently to clear nostrils. 2. Tilt head slightly back. 3. Insert applicator tip just inside nostril, pointing away from the nasal septum. 4. Squeeze/spray while breathing in gently through the nose. 5. Avoid sniffing hard. 6. Do not share the bottle/dropper to prevent contamination. Use for a maximum of 5-7 consecutive days.
5. Side Effects
Common side effects may include:
- Transient local burning
- Stinging sensation
- Sneezing
- Dryness of nasal mucosa
- Mild headache
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - e.g., Phenelzine, Tranylcypromine | Potentiates pressor effects, risk of severe hypertensive crisis. | Contraindicated |
| Tricyclic Antidepressants (TCAs) - e.g., Amitriptyline | May potentiate pressor effects of xylometazoline. | Major |
| Other Sympathomimetics (Oral/Parenteral) - e.g., Pseudoephedrine, Epinephrine | Additive sympathomimetic effects, increasing risk of hypertension, tachycardia. | Major |
| Beta-blockers (non-selective) - e.g., Propranolol | Unopposed alpha-adrenergic stimulation may lead to severe hypertension and bradycardia. | Moderate |
| Methyldopa | May enhance pressor response. | Moderate |
| Ergot Alkaloids - e.g., Ergotamine | Increased risk of severe vasoconstriction and ischemia. | Major |
7. Patient Counselling
- DO use exactly as prescribed, not more frequently or for longer than 5-7 days.
- DO blow your nose gently before use.
- DO clean the applicator tip with a clean tissue after each use.
- DO NOT use if the solution is discolored.
- DO NOT share your nasal spray with anyone.
- DO NOT tilt head back too far to avoid swallowing the medication.
- DO NOT use to treat symptoms other than nasal congestion.
8. Toxicology & Storage
Overdose: Systemic: Severe hypertension, headache, reflex bradycardia, palpitations, anxiety, insomnia, tremors, sweating, nausea. CNS: Drowsiness, deep sleep (especially in children), hypothermia, coma. Respiratory: Apnea. Local: Severe rebound congestion, burning, stinging.
Storage: Store at room temperature (15-25°C), protected from light and moisture. Do not freeze. Keep the bottle tightly closed. Keep out of reach and sight of children. Discard as per expiry date.